173 related articles for article (PubMed ID: 32955607)
1. Preoperative versus pathological staging of rectal cancer-challenging the indication of neoadjuvant chemoradiotherapy.
Fritz S; Killguss H; Schaudt A; Lazarou L; Sommer CM; Richter GM; Küper-Steffen R; Feilhauer K; Köninger J
Int J Colorectal Dis; 2021 Jan; 36(1):191-194. PubMed ID: 32955607
[TBL] [Abstract][Full Text] [Related]
2. Local recurrence after five years is associated with preoperative chemoradiotherapy treatment in patients diagnosed with stage II and III rectal cancer.
Marin G; Suárez J; Vera R; Balén E; Viudez A; Mata E
Int J Surg; 2017 Aug; 44():15-20. PubMed ID: 28583894
[TBL] [Abstract][Full Text] [Related]
3. Significance of MRI in rectal carcinoma therapy optimization - correlation of preoperative T- and N-staging with definitive histopathological findings.
Danihel L; Danihel L; Rajcok M; Mosna K; Belan V; Varga I; Schnorrer M
Neoplasma; 2019 May; 66(3):494-498. PubMed ID: 30793609
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
[TBL] [Abstract][Full Text] [Related]
5. MRI-based parameters and clinical risk factors to predict lymph node metastasis in patients with ypT0 rectal cancer after neoadjuvant chemoradiotherapy.
Wang Y; Wang X; Huang S; Chen J; Huang Y
ANZ J Surg; 2024 Jun; 94(6):1127-1132. PubMed ID: 38251776
[TBL] [Abstract][Full Text] [Related]
6. Tumour stage and preoperative chemoradiotherapy influence the lymph node yield in stages I-III rectal cancer: results from a prospective nationwide cohort study.
Lykke J; Roikjaer O; Jess P;
Colorectal Dis; 2014 Apr; 16(4):O144-9. PubMed ID: 24329928
[TBL] [Abstract][Full Text] [Related]
7. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
[TBL] [Abstract][Full Text] [Related]
8. The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy.
Cote A; Florin FG; Mois E; Elisei R; Badea R; Mare C; Hajjar NA; Iancu C; Lebovici A
Ann Ital Chir; 2018; 89():168-176. PubMed ID: 29848812
[TBL] [Abstract][Full Text] [Related]
9. Lymph node status as a prognostic indicator after preoperative neoadjuvant chemoradiotherapy of rectal cancer.
Mirbagheri N; Kumar B; Deb S; Poh BR; Dark JG; Leow CC; Teoh WM
Colorectal Dis; 2014 Oct; 16(10):O339-46. PubMed ID: 24916286
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging in restaging rectal cancer after neoadjuvant chemoradiotherapy.
Zhan S; Wang X; Huang X; Zhu H
J BUON; 2015; 20(1):62-7. PubMed ID: 25778298
[TBL] [Abstract][Full Text] [Related]
11. Effects of neoadjuvant chemotherapy plus chemoradiotherapy on lymph nodes in rectal adenocarcinoma.
Chotard G; Capdepont M; Denost Q; Smith D; Vendrely V; Rullier E; Rullier A
Virchows Arch; 2021 Oct; 479(4):657-666. PubMed ID: 33983519
[TBL] [Abstract][Full Text] [Related]
12. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
[TBL] [Abstract][Full Text] [Related]
13. The impact of lymph node size to predict nodal metastasis in patients with rectal cancer after preoperative chemoradiotherapy.
Kim IK; Kang J; Lim BJ; Sohn SK; Lee KY
Int J Colorectal Dis; 2015 Apr; 30(4):459-64. PubMed ID: 25586204
[TBL] [Abstract][Full Text] [Related]
14. MRI-based guidelines for selective neoadjuvant treatment in rectal cancer: Does MRI adequately predict the indication for radiotherapy in daily practice in a large teaching hospital.
Tersteeg JJC; Crolla RMPH; Gobardhan PD; Kint PAM; Niers-Stobbe I; Boonman-de Winter L; Arnold DE; Rozema T; Schreinemakers JMJ
Eur J Cancer Care (Engl); 2020 Mar; 29(2):e13190. PubMed ID: 31863608
[TBL] [Abstract][Full Text] [Related]
15. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
[TBL] [Abstract][Full Text] [Related]
16. Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer.
Lee D; Matsuda T; Yamashita K; Hasegawa H; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Fukumoto T; Kakeji Y
Anticancer Res; 2019 Feb; 39(2):993-998. PubMed ID: 30711986
[TBL] [Abstract][Full Text] [Related]
17. Indications for Lateral Pelvic Lymph Node Dissection Based on Magnetic Resonance Imaging Before and After Preoperative Chemoradiotherapy in Patients with Advanced Low-Rectal Cancer.
Akiyoshi T; Matsueda K; Hiratsuka M; Unno T; Nagata J; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S614-20. PubMed ID: 25896145
[TBL] [Abstract][Full Text] [Related]
18. Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal Cancer.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Kim J; Wong JY; Chen YJ
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S580-7. PubMed ID: 25956577
[TBL] [Abstract][Full Text] [Related]
19. Reevaluation of Preoperative Chemoradiotherapy for Clinical T3 Lower Rectal Cancer: A Multicenter Collaborative Retrospective Clinical Study.
Takeda M; Kawahara H; Ogawa M; Suwa K; Eto K; Yanaga K
Anticancer Res; 2019 Jun; 39(6):3047-3052. PubMed ID: 31177147
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors related to lymph node metastases after neoadjuvant therapy for locally advanced rectal cancer].
Zeng ZF; Ding PR; Pan ZZ; Lin JZ; Li LR; Lu ZH; Wu XJ; Kong LH; Zhou ZG; Wan DS
Ai Zheng; 2009 Sep; 28(9):923-7. PubMed ID: 19728908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
